Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats

EM Hamad, M Sato, K Uzu, T Yoshida… - British journal of …, 2008 - cambridge.org
We have demonstrated previously that a diet containing skimmed milk (SM) fermented by
Lactobacillus gasseri SBT2055 (LGSP) reduces adipocyte size in Sprague–Dawley rats …

Oil from the marine zooplankton Calanus finmarchicus improves the cardiometabolic phenotype of diet-induced obese mice

AC Höper, W Salma, AM Khalid, AD Hafstad… - British Journal of …, 2013 - cambridge.org
The aim of the present study was to investigate the effects of oil extracted from the
zooplankton Calanus finmarchicus (Calanus oil) on diet-induced obesity and obesity-related …

Inhibition of cholesterol absorption: targeting the intestine

SD Lee, P Gershkovich, JW Darlington… - Pharmaceutical …, 2012 - Springer
Atherosclerosis, the gradual formation of a lipid-rich plaque in the arterial wall is the primary
cause of Coronary Artery Disease (CAD), the leading cause of mortality worldwide …

Lactiplantibacillusplantarum ATG-K2 Exerts an Anti-Obesity Effect in High-Fat Diet-Induced Obese Mice by Modulating the Gut Microbiome

YS Lee, EJ Park, GS Park, SH Ko, J Park… - International Journal of …, 2021 - mdpi.com
Obesity is a major health problem. Compelling evidence supports the beneficial effects of
probiotics on obesity. However, the anti-obesity effect of probiotics remains unknown. In this …

The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression …

K Sachs-Barrable, JW Darlington… - Lipids in Health and …, 2014 - Springer
Background Many drugs are substrates for P-glycoprotein (P-gp) and interactions involving
P-gp may be relevant to clinical practice. Co-administration with P-gp inhibitors or inducers …

Phytosterols do not change susceptibility to obesity, insulin resistance, and diabetes induced by a high-fat diet in mice

L Calpe-Berdiel, JC Escola-Gil, N Rotllan… - Metabolism, 2008 - Elsevier
Most studies have focused on the cholesterol-lowering activity of phytosterols; however,
other biological actions have also been attributed to these plant compounds. In this study …

Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of …

J Méndez-González, S Süren-Castillo… - British journal of …, 2010 - cambridge.org
Disodium ascorbyl phytostanol phosphate (FM-VP4) is a synthetic compound derived from
sitostanol and campestanol that has proved to be efficient as a cholesterol-lowering therapy …

Discontinued drugs in 2008: endocrine and metabolic

JR Colca - Expert Opinion on Investigational Drugs, 2009 - Taylor & Francis
This perspective summarizes key compounds from the endocrine and metabolic area that
were discontinued during the calendar year 2008. This is a continuation in a series of …

Dietary supplementation with phytosterol and ascorbic acid reduces body mass accumulation and alters food transit time in a diet-induced obesity mouse model

SJ Thornton, ITY Wong, R Neumann… - Lipids in Health and …, 2011 - Springer
Previous research indicates that animals fed a high fat (HF) diet supplemented with
disodium ascorbyl phytostanyl phosphate (DAPP) exhibit reduced mass accumulation when …

植物甾醇对大鼠脂质代谢紊乱的预防作用

杨科峰, 房玥晖, 张雄 - 上海交通大学学报(医学版), 2010 - xuebao.shsmu.edu.cn
目的研究植物甾醇对高脂饮食大鼠脂质代谢的影响. 方法40 只雄性SD 大鼠随机分为基础对照组
(普通饲料喂养), 高脂模型组(高脂饲料喂养), 植物甾醇低剂量组(高脂饲料喂养, 每天100 mg/kg …